Overview

  • Product nameAnti-WDR17 antibody
  • Description
    Rabbit polyclonal to WDR17
  • Tested applicationsSuitable for: IHC-P, ICC/IFmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    antigen sequence: EDVVAFVSHR GPLFIWTISG PDSGVIVHKD AHSFLSDICM FRWHTHQKGK VVFGHIDGSL SIFHPGNKNQ KHVLRPESLE GTDEEDPVTA LEWDPLST, corresponding to amino acids 139-236 of Human WDR17.

  • Positive control
    • Human pancreas tissue.

Properties

  • FormLiquid
  • Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
  • Storage bufferpH: 7.20
    Preservative: 0.02% Sodium azide
    Constituents: 59% PBS, 40% Glycerol
  • Concentration information loading...
  • PurityImmunogen affinity purified
  • ClonalityPolyclonal
  • IsotypeIgG
  • Research areas

Associated products

Applications

Our Abpromise guarantee covers the use of ab122813 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IHC-P 1/200 - 1/500. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
ICC/IF Use a concentration of 1 - 4 µg/ml.

Recommend PFA Fixation and Triton X-100 treatment

Target

Anti-WDR17 antibody images

  • Immunofluorescent staining of Human cell line A-431 shows positivity in nucleus but not nucleoli. Recommended concentration of ab122813 1-4 µg/ml. Cells treated with PFA/Triton X-100.
  • ab122813, at 1/200 dilution, staining WDR17 in paraffin-embedded Human pancreas tissue by Immunohistochemistry.

References for Anti-WDR17 antibody (ab122813)

ab122813 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab122813.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"